CLOSEOUT LETTER
Kuiper Dairy, LLC
- Recipient:
- Kuiper Dairy, LLC
United States
- Issuing Office:
United States
| Food and Drug Administration |
| Dallas District Office 4040 North Central Expressway Suite 300 Dallas, Texas 75204-3128 |
Department of Health and Human Services
June 29, 2015
CERTIFIED MAIL
RETURN RECEIPT REQUESTED
Clemens Kuiper, Owner
Kuiper Dairy, LLC.
1865 PR 1233
Hico, Texas 76457
Dear Mr. Kuiper:
The Food and Drug Administration has completed an evaluation of your firm's violative tissue residue history since receiving Warning Letter 2013-DAL-WL-022 issued December 19, 2012. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Shari J. Shambaugh
Director, Compliance Branch
Dallas District